SUVEN — Suven Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	504	2,284	2,399	600	5,181
Net Total Accounts Receivable
Net Total Receivables	147	206	155	142	71.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	666	2,516	2,567	755	5,467
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	409	370	280	595	764
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,080	3,889	2,849	1,352	6,242
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	83.1	111	135	235	309
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	119	136	149	252	328
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	961	3,753	2,700	1,100	5,914
Total Liabilities & Shareholders' Equity	1,080	3,889	2,849	1,352	6,242
Total Common Shares Outstanding